R. Hanover

Publications12
h-index7
Citations155
Highly Influential Citations11
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Liebowitz
  • 434 Publications • 30,792 Citations
  • P. Jacobsen
  • 34 Publications • 928 Citations
  • A. Mahableshwarkar
  • 47 Publications • 1,325 Citations
  • F. Schneier
  • 179 Publications • 12,765 Citations
  • Publications
  • Influence
Staying on track: a cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion.
OBJECTIVES To evaluate whether automated reminders increase on-time completion of the three-dose human papillomavirus (HPV) vaccine series. METHODS Ten reproductive health centers enrolled 365… Expand
  • 50
  • 7
Full-Wave, Non-Linear, Inverse Scattering
  • 52
  • 2
Effect of an acute intranasal aerosol dose of PH94B on social and performance anxiety in women with social anxiety disorder.
OBJECTIVE Although social anxiety disorder is a common and sometimes disabling condition, there are no approved treatments that can be used on an as-needed basis. The authors examined the acute use… Expand
  • 13
  • 2
Effect of as‐needed use of intranasal PH94B on social and performance anxiety in individuals with social anxiety disorder
There are no medications approved for as‐needed use for feared situations for individuals with social anxiety disorder (SAD). In the present study, intranasal PH94B was provided for use as needed… Expand
  • 8
A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder.
OBJECTIVE To examine the efficacy, safety, and tolerability of vilazodone for subjects (aged 18-75 years) with generalized social anxiety disorder. METHOD Forty-four subjects with generalized… Expand
  • 7
Is V̇O2max an Appropriate Fitness Indicator for Older Adults
Older individuals arc more likely than younger adults to exhibit symptoms of exercise intolerance at high work rates. The risks of maximal exercise in older adults increase proportionally as the… Expand
  • 9
Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder
Major Depressive Disorder (MDD) and Social Anxiety Disorder (SAD) are highly comorbid, yet the combined condition has not been subject to any placebo‐controlled treatment trials. This study reports a… Expand
  • 10
Producing comparable cost and quality results from all-payer claims databases.
OBJECTIVES To describe how all-payer claims databases (APCDs) can be used for multistate analysis, evaluating the feasibility of overcoming the common barrier of a lack of standardization across data… Expand
  • 1
Provider perceptions of burnout while engaging in end-of-life care conversations: A pilot study using the Serious Illness Conversation Guide.
19 Background: Studies recommend improved attention to patient end-of-life (EOL) care preferences and there is evidence that effective provider-patient EOL care conversations yield positive patient… Expand
A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Desvenlafaxine Extended-Release Tablets in Generalized Social AnxietyDisorder
Abstract Objective: The purpose of the study was to asses the efficacy of desvenlafaxine in patients with the generalized form of Social Anxiety Disorder (GSAD). Methods: 63 patients with GSAD were… Expand
  • 1
...
1
2
...